Diametric Capital, LP Novartis Ag Transaction History

Diametric Capital, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $2.01 Million - $2.82 Million	-28,510 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $2.4 Million - $2.72 Million	28,510 New	28,510 $2.7 Million
Q3 2019 Nov 13, 2019	SELL	$85.54 - $94.26 $5.47 Million - $6.03 Million	-63,941 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $1.64 Million - $2.02 Million	21,743 Added 51.53%	63,941 $5.84 Million
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $1.07 Million - $1.22 Million	14,150 Added 50.45%	42,198 $3.57 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $1.54 Million - $1.72 Million	20,955 Added 295.43%	28,048 $2.16 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $474,805 - $549,210	7,093 New	7,093 $611,000

1,439

135M

1.12M

1.82M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.